Biovica International AB (publ)

Stockholm Stock Exchange BIOVIC-B.ST

Biovica International AB (publ) Share Price on January 14, 2025: USD 0.16

Biovica International AB (publ) Share Price is USD 0.16 on January 14, 2025, a -37.57% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.

Biovica International AB (publ) 52-week high Share Price is USD 0.28 on September 16, 2024, which is 74.76% above the current Share Price.
Biovica International AB (publ) 52-week low Share Price is USD 0.14 on May 14, 2024, which is -11.07% below the current Share Price.
Biovica International AB (publ) average Share Price for the last 52 weeks is USD 0.22.

Key data

Date	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)

Stockholm Stock Exchange: BIOVIC-B.ST

Biovica International AB (publ)

CEO	Mr. Anders Rylander
IPO Date	March 29, 2017
Location	Sweden
Headquarters	Dag HammarskjOelds vAeg 54B
Employees	27
Sector	Health Care
Industries Biotechnology Pharmaceuticals

Description

Biovica International AB (publ), a biotechnology company, develops and commercializes blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in Sweden and internationally. It primarily focuses on breast cancer. The company develops DiviTum, a biomarker assay that measures the activity of the enzyme thymidine kinase-1 in blood serum or cell cultures. It serves cancer institutes, pharmaceutical companies, and collaborative groups. The company was incorporated in 2008 and is headquartered in Uppsala, Sweden.

Key trends

Past 5 years